Teva Pharmaceutical Industries Operating Expenses 2010-2024 | TEVA

Teva Pharmaceutical Industries operating expenses for the twelve months ending December 31, 2024 were $16.847B, a 9.3% increase year-over-year.

  • Teva Pharmaceutical Industries annual operating expenses for 2024 were $16.847B, a 9.3% increase from 2023.
  • Teva Pharmaceutical Industries annual operating expenses for 2023 were $15.413B, a 9.98% decline from 2022.
  • Teva Pharmaceutical Industries annual operating expenses for 2022 were $17.122B, a 20.89% increase from 2021.

Teva Pharmaceutical Industries Operating Expenses 2010-2024 | TEVA

  • Teva Pharmaceutical Industries annual operating expenses for 2024 were $16.847B, a 9.3% increase from 2023.
  • Teva Pharmaceutical Industries annual operating expenses for 2023 were $15.413B, a 9.98% decline from 2022.
  • Teva Pharmaceutical Industries annual operating expenses for 2022 were $17.122B, a 20.89% increase from 2021.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M